Rhenman & Partners Asset Management Ab Edwards Lifesciences Corp Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $8.22 Million - $9.2 Million	97,500 New	97,500 $9.01 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $2.01 Million - $2.71 Million	29,000 New	29,000 $2.01 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $3.34 Million - $3.87 Million	-41,000 Reduced 58.57%	29,000 $2.74 Million
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $5.5 Million - $6.25 Million	-74,000 Reduced 51.39%	70,000 $5.79 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $1.3 Million - $1.66 Million	19,000 Added 15.2%	144,000 $10.7 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $6.59 Million - $8.58 Million	80,000 Added 177.78%	125,000 $9.05 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $1.73 Million - $2.57 Million	-20,000 Reduced 30.77%	45,000 $4.28 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $3.57 Million - $4.49 Million	-35,000 Reduced 35.0%	65,000 $7.65 Million
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $531,850 - $653,400	-5,000 Reduced 4.76%	100,000 $13.1 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $514,550 - $613,750	-5,000 Reduced 4.55%	105,000 $11.9 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $1.18 Million - $1.36 Million	-15,000 Reduced 12.0%	110,000 $9.2 Million
Q4 2020 Jan 19, 2021	BUY	$71.69 - $91.23 $358,450 - $456,150	5,000 Added 4.17%	125,000 $11.4 Million
Q2 2020 Jul 16, 2020	BUY	$57.54 - $76.95 $3.63 Million - $4.85 Million	63,000 Added 110.53%	120,000 $8.29 Million
Q1 2020 Apr 16, 2020	BUY	$52.41 - $81.0 $995,789 - $1.54 Million	19,000 Added 50.0%	57,000 $10.8 Million
Q4 2019 Jan 17, 2020	BUY	$71.7 - $82.09 $101,455 - $116,157	1,415 Added 3.87%	38,000 $8.87 Million
Q3 2019 Oct 16, 2019	BUY	$61.55 - $75.43 $307,750 - $377,150	5,000 Added 15.83%	36,585 $8.05 Million
Q2 2019 Jul 22, 2019	BUY	$55.74 - $64.41 $278,700 - $322,050	5,000 Added 18.81%	31,585 $5.84 Million
Q1 2019 Apr 11, 2019	SELL	$47.89 - $64.05 $1.92 Million - $2.56 Million	-40,000 Reduced 60.07%	26,585 $5.09 Million
Q4 2018 Feb 05, 2019	SELL	$46.41 - $56.94 $1.39 Million - $1.71 Million	-30,000 Reduced 31.06%	66,585 $10.2 Million
Q3 2018 Oct 03, 2018	BUY	$45.7 - $58.03 $1.29 Million - $1.64 Million	28,221 Added 41.28%	96,585 $16.8 Million
Q2 2018 Jul 20, 2018	SELL	$42.45 - $51.3 $636,750 - $769,500	-15,000 Reduced 17.99%	68,364 $9.95 Million
Q1 2018 Apr 11, 2018	BUY	$37.19 - $47.45 $371,900 - $474,500	10,000 Added 13.63%	83,364 $11.6 Million
Q4 2017 Jan 19, 2018	SELL	$33.79 - $39.39 $224,230 - $261,392	-6,636 Reduced 8.3%	73,364 $8.27 Million
Q3 2017 Oct 13, 2017	BUY	$36.29 - $38.83 $2.9 Million - $3.11 Million	80,000	80,000 $8.75 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account